Non‐Vitamin K Antagonist Oral Anticoagulants Provide Less Adverse Renal Outcomes Than Warfarin In Non‐Valvular Atrial Fibrillation: A Systematic Review and MetaAnalysis

BACKGROUND: Non‐vitamin K antagonist oral anticoagulants (NOACs) have better pharmacologic properties than warfarin and are recommended in preference to warfarin in most patients with non‐valvular atrial fibrillation. Besides lower bleeding complications, other advantages of NOACs over warfarin part...

Descripción completa

Detalles Bibliográficos
Autores principales: Sitticharoenchai, Patita, Takkavatakarn, Kullaya, Boonyaratavej, Smonporn, Praditpornsilpa, Kearkiat, Eiam‐Ong, Somchai, Susantitaphong, Paweena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Systematic Review and Meta‐analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8174352/
https://www.ncbi.nlm.nih.gov/pubmed/33728927
http://dx.doi.org/10.1161/JAHA.120.019609

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8174352/
https://www.ncbi.nlm.nih.gov/pubmed/33728927
http://dx.doi.org/10.1161/JAHA.120.019609

Ejemplares similares